BREAKING NEWS: J&J vaccinations could resume THIS WEEKEND: Health officials expected to say the pause can be lifted – but the shot will come with a warning about blood clots like the EU’s
- Two U.S. officials told the Washington Post the pause will likely be lifted
- Vaccinations with the one-dose shot could resume as soon as this weekend
- J&J’s shot will likely have to carry a warning about rare, but life-threatening blood clots, seen in at least 7 people, including 6 women under 50
- Officials said the CDC is unlikely to recommend an age restriction on who can get the shot
U.S. health officials will likely say that vaccinations with Johnson & Johnson’s single-dose shot can resume, as early as this weekend.
Two U.S. officials told the Washington Post that the vaccine will likely now carry a warning about rare, but potentially life-threatening blood clots, similar to one used in the EU.
Vaccinations with J&J’s shot were paused last week after seven reports of a rare possible reaction to the vaccine involving blood clots. Six of the reactions were in women aged 18 to 48.
Regulators are not expected to place an age limit on who can receive the vaccine.
No doses made at the plant have been shipped in the U.S. and distribution of the shot is paused amid blood clot concerns